Cook Meredith's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Feb 17, 2026
- Accession no.
- 0001938861-26-000006
- Filed
- Feb 17, 2026
- Trade date
- Feb 12-14, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $38.4K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cook MeredithCIK 0001938861 | Officer (SR. VP, GENERAL COUNSEL & SEC.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Common Stock | FTax withholdingDisposed | −1,534 | $76.70 | −$117,657.8 | 69,829 | Direct | |
| Feb 13, 2026 | Common Stock | SSaleDisposed | −500 | $76.80 | −$38,400 | 69,329 | Direct | |
| Feb 14, 2026 | Common Stock | FTax withholdingDisposed | −1,779 | $77.36 | −$137,623.44 | 67,550 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.